SCHEMBL21362630

SCHEMBL21362630

C=Cc1ccc(C(=O)c2cc(F)c(C)cc2Br)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
RXRA P19793 2/20 0.37
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MEN1 O00255 1/20 0.34
LSS P48449 1/20 0.34
KMT2A Q03164 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158155 0.84 HDAC1 (0.42) HPGDHDAC1HDAC6RXRAMAPT
SCHEMBL20157891 0.80 KDM1A (0.43) HPGDMAPTNPC1MAPK1HTT
SCHEMBL21362471 0.78 MAPT (0.50) HPGDRXRAMAPTNPC1MAPK1
SCHEMBL21362817 0.77 HPGD (0.39) HPGDMAPTTAS1R3TAS1R1KDM4E
SCHEMBL13445698 0.75 RAB9A (0.38) HPGDRXRAMAPTNPC1RAB9A
SCHEMBL20157472 0.73 CES2 (0.38) HPGDRXRAMAPTHTTSMN1; SMN2
SCHEMBL13583809 0.71 MAPK13 (0.49) NPC1HTTRAB9AALDH1A1TDP1
SCHEMBL21362746 0.70 TAS1R3 (0.35) HPGDRXRAMAPTHTTSMN1; SMN2
SCHEMBL6744336 0.70 TSHR (0.44) HPGDHDAC1HDAC6MAPTNPC1
SCHEMBL851686 0.70 LCK (0.48) HPGDHDAC1HDAC6SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed